The regulatory landscape for medical devices, in-vitro diagnostics (IVDs), and other healthcare technologies is evolving rapidly in 2025. These changes aim to enhance safety, sustainability, and innovation while ensuring businesses comply effectively with new requirements. This blog will walk you through key developments, including updated EU regulations on medical devices, batteries, AI, packaging, and substance restrictions under REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals).
Medical Device Regulations: Enhancing Safety and Vigilance
The EU Regulation (EU) 2024/1860 mandates that as of January 10, 2025, manufacturers must notify competent authorities and health institutions in advance of any disruption or discontinuation of their medical device supplies. This provision ensures that interruptions do not pose risks to public health. The rule applies to all device types, including legacy models, and affects both EU based and non EU based manufacturers.
The MDR establishes stringent standards for medical device safety, quality, and post-market vigilance. Article 10 defines the general obligations of manufacturers throughout the device lifecycle, from design and manufacturing to post-market surveillance and continuous improvement.
To comply, companies must align with a Quality Management System (QMS) that covers:
- Regulatory compliance strategies
- Resource qualifications and responsibilities
- Internal audits and vigilance systems
- Labeling and biocompatibility documentation
A well-maintained QMS helps manufacturers assess risks, detect potential issues early, and demonstrate conformity with safety and performance standards outlined in the General Safety and Performance Requirements (GSPR).
Key Obligations for Manufacturers Under MDR Article 10
- Design and manufacture devices according to MDR requirements
- Implement risk management (Annex I, Section 3)
- Conduct clinical evaluation per Article 61 and Annex XIV, including PMCF
- Maintain technical documentation as specified in Annexes II and III
- Provide documentation for custom-made devices as per Annex XIII
- Prepare an EU Declaration of Conformity
- Implement a Unique Device Identification (UDI) system (Article 27)
- Retain technical documentation and certificates for 10-15 years after the last device is placed on the market
- Establish procedures for conformity, change control, and compliance
- Implement a post-market surveillance system (Article 83)
- Ensure appropriate labeling and information
- Plan corrective actions, withdrawals, and recalls
- Implement systems for recording and reporting incidents and field safety actions
- Maintain documentation for regulatory authorities and ensure cooperation
- Define responsibilities for outsourcing activities
- Provide compensation for damages caused by defective devices
Technical Documentation: The Foundation of Compliance
Technical documentation serves as the foundation of regulatory compliance. Manufacturers must provide evidence demonstrating conformity with MDR requirements, including:
- Device description and intended purpose
- Manufacturing information detailing production processes and materials
- Risk assessment and safety measures
- Verification and validation data from clinical and laboratory testing
The GSPR (Annex I) mandates adherence to risk reduction, performance, and packaging standards. Compliance requires appropriate risk management strategies, usability studies, and supporting technical documentation.
Risk Management and Clinical Evaluation
Under MDR, manufacturers must establish a comprehensive risk management system that continuously evaluates potential hazards throughout a device’s lifecycle. This includes:
- Identifying and mitigating risks
- Monitoring post-market performance through surveillance systems
- Conducting clinical evaluations and post-market clinical follow-ups (PMCF)
Clinical evaluation is critical for demonstrating device safety and effectiveness, requiring pre-market studies and continuous post-market data collection.
To learn more about risk management, check out our Risk Management Blog Collection.
Post-Market Surveillance and Vigilance
Post-market surveillance (PMS) ensures that manufacturers monitor device performance and address emerging risks. PMS activities include:
- Collecting and analyzing real world performance and safety data
- Reporting incidents and corrective actions to authorities
- Using PMS findings to enhance product development and compliance
The EUDAMED database plays a central role in tracking PMS data, promoting transparency and collaboration between manufacturers, regulators, and notified bodies.
Sustainability Spotlight: The New Batteries Regulation
One of the major regulatory changes in 2025 is the EU Batteries Regulation, which enhances sustainability across the battery lifecycle. This regulation applies to all battery types, including those integrated into medical devices.
Key Provisions of the Batteries Regulation
- Battery Lifecycle Management: Sourcing, recycling, and waste management
- Supply chain transparency: Businesses must document battery materials and components.
- Mandatory CE Marking: As of August 2024, all batteries require CE marking.
- Digital Battery Passport: By February 2027, industrial and transport batteries must have digital passports for traceability and recycling.
Manufacturers should conduct internal assessments and collaborate with suppliers to ensure compliance with durability, labeling, and recycling standards.
Navigating the EU AI Act: Dual Compliance for High Risk AI Systems
The EU AI Act, effective as of August 2024, introduced a risk-based approach to AI regulation. AI systems used in medical devices or diagnostics that may impact safety, health, or fundamental rights are classified as high risk; requiring compliance with both the AI Act and MDR/IVDR.
Key AI Compliance Areas
- Data Governance: Transparent, structured data management, documentation
- Risk Management: Mitigation of AI specific risks, Accuracy, Cybersecurity
- Post-Market Surveillance: Continuous monitoring of AI system performance and safety
Manufacturers must undergo conformity assessments, maintain technical documentation, and cooperate with regulatory authorities. Compliance deadlines extend through 2030.
Packaging and Waste Reduction: Meeting New Sustainability Standards
The EU’s new packaging regulations mandate that all packaging must be recyclable by 2030, with targets to reduce plastic waste by 20% by 2040. However, exemptions apply for medical device packaging, particularly contact-sensitive materials.
Key Items
- Plastic waste reduction: 10% decrease by 2030, 20% by 2040
- Material labeling: By end of 2029, packaging must indicate information on its material composition and reusability
Manufacturers should evaluate packaging strategies to ensure compliance while maintaining product safety and effectiveness.
Substance Restrictions Under REACH
The REACH regulation enforces strict controls on hazardous substances, with ongoing updates to the Candidate List. Manufacturers must:
- Identify SVHCs (Substances of Very High Concern) in their products
- Communicate SVHC safety information to stakeholders and consumers upon request
- Monitor regulatory updates and phase out restricted substances where necessary
Proactively managing material compliance ensures continued market access and regulatory approval.
Final Thoughts: Prepare Now for 2025 Compliance
As we enter 2025, the evolving regulatory landscape demands proactive planning and execution. From MDR compliance to sustainability regulations and AI integration, companies must ensure their systems are up-to-date, robust, and adaptable.
At Ventura Solutions, we specialize in helping medical device companies navigate complex regulatory challenges. Whether you need support with EU MDR compliance, technical documentation, risk management, training, or more, our team of experts is ready to assist. Contact us today to ensure your organization stays ahead of these regulatory changes and maintains seamless market access.
Want to stay ahead of regulatory updates and industry trends? Subscribe to our newsletter below for expert insights, the latest developments in medical device and combination product regulations, and exciting career opportunities.
